News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

3 Beaten-Up Biotechs Bouncing Back In 2017



7/24/2017 6:16:23 AM

  Life Sciences Jobs  
  • Newest Jobs - Last 24 Hours
  • California Jobs
  • Massachusetts Jobs
  • New Jersey Jobs
  • Maryland Jobs
  • Washington Jobs
  View More Jobs
Not every stock that falls on tough times is worth buying in portfolios, but sometimes, catalysts can spark shareholder-friendly rallies, and in those situations, it can make sense. For example, risk-tolerant investors might want to consider picking up shares in the beaten-up biotech stocks Zogenix (NASDAQ:ZGNX), Insys Therapeutics (NASDAQ:INSY), and Keryx Pharmaceuticals (NASDAQ:KERX). All three of these stocks are former highfliers, and each has catalysts that could help them regain some of their former glory.

Read at Motley Fool


comments powered by Disqus
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES